Mcloughlin Margaret Insider Trades

Insider Trading History

Track insider trading activity for Mcloughlin Margaret. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $27.8k 27,000 shares
Last Trade
Jun 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$29.4k 27,000 shares
$1.09
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $32.6k 31,613 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59.4k 31,613 shares
$1.88
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $27.8k 27,000 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.1k 27,000 shares
$0.82
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $8.24k 8,000 shares
Last Trade
Aug 08, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.84k 8,000 shares
$1.23
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $27.8k 27,000 shares
Last Trade
May 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.7k 27,000 shares
$1.58
$1.03
Cortexyme
Cortexyme CRTX
Director
Holding Value $52.7k 27,000 shares
Last Trade
Jun 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$87.2k 27,000 shares
$3.23
$1.95
Cortexyme
Cortexyme CRTX
Director
Holding Value $0 0 shares
Last Trade
Oct 08, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$88.9k 1,000 shares
$88.93
$1.95
Cortexyme
Cortexyme CRTX
Director
Holding Value $166k 84,911 shares
Last Trade
Oct 08, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$87.5k 1,000 shares
$87.49
$1.95
Cortexyme
Cortexyme CRTX
Director
Holding Value $1.95k 1,000 shares
Last Trade
Oct 08, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$87.5k 1,000 shares
$87.49
$1.95
Cortexyme
Cortexyme CRTX
Director
Holding Value $11.7k 6,000 shares
Last Trade
Aug 16, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$568k 6,000 shares
$94.60
$1.95
Cortexyme
Cortexyme CRTX
Director
Holding Value $5.74k 2,944 shares
Last Trade
Aug 16, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$573k 6,000 shares
$95.44
$1.95
Cortexyme
Cortexyme CRTX
Director
Holding Value $168k 85,911 shares
Last Trade
Aug 16, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$568k 6,000 shares
$94.60
$1.95
Cortexyme
Cortexyme CRTX
Director
Holding Value $683 350 shares
Last Trade
Jun 28, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$30.3k 550 shares
$55.15
$1.95
Cortexyme
Cortexyme CRTX
Director
Holding Value $21.5k 11,029 shares
Last Trade
Jun 16, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$558k 11,029 shares
$50.56
$1.95
Cortexyme
Cortexyme CRTX
Director
Holding Value $21.5k 11,029 shares
Last Trade
Jun 08, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$460k 11,029 shares
$41.73
$1.95
Cortexyme
Cortexyme CRTX
Director
Holding Value $1.07k 550 shares
Last Trade
May 13, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$13.1k 550 shares
$23.90
$1.95

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up